Delivery Order SPE2DR25D1100-SPE2DR26FCN2W
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for the supply of LENVIMA 18 mg daily dose in quantities of 90 units. This competitively awarded, firm fixed-price delivery order was issued on October 21, 2025, with an ultimate completion date of November 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for Lenvima 10 mg daily dose tablets (30-count package) on June 30, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency awarded a $9,910.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 MG daily dose (60-count supply) on June 18, 2025, with completion targeted for July 11, 2025. This non-set-aside contract represents a direct pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count quantity, with a ceiling value of $10,223.24 and a firm fixed price structure. The contract carries an ultimate completion date of November 18, 2025, and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for the supply of Lenvima 8 mg daily dose in a quantity of 60 tablets. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, reflecting open competition among eligible vendors. This delivery...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count supply) on November 3, 2025, with completion targeted for November 25, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $10,773.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lenvima 8 mg daily dose tablets (60-unit supply) on October 27, 2025, with completion targeted for November 18, 2025. This award represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lenvima 10 mg daily dose (30-count supply) under a firm fixed price contract valued at $10,223.24. The order is scheduled for completion by August 27, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and deliver the pharmaceutical product as part of its extensive federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,223.24 on August 18, 2025, for the supply of LENVIMA 10 mg daily dose tablets (30-count) under a firm fixed-price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 9, 2025. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for the supply of Lenvima 18 mg daily dose tablets (90-count package). This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 26, 2025, and represents fulfillment under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCN2WDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for Lenvima 18 mg daily dose, a 90-day supply. The contract is a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. Performance will take place at the vendor's corporate office in Conshohocken. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This master contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Lenvima, a specialty oncology medication, represents the type of specialized pharmaceutical product the company delivers under this agreement to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 11/7/25 |